Monday, 23 June 2014

WHAT DO WE CALL THE PASSING OF TRAITS FROM PARENT TO CHILD?

The term used to describe the transfer of traits from parent to child is heredity.  Our genes come from our parents so it is only natural to assume that we will be like our parents.  A little bit like our mothers, and a little bit like our fathers, there’s probably a bit of you in there somewhere too.

Genes, or DNA, carry our biological information, our hair color, our general height, sometimes even our attitudes.  This question is much more expansive than it may seem, not because the answer is expansive, but because we inherit traits from more than our parents.  We get them from grand parents, and even generations beyond them.
Each of us has enough information in our genes to make quite a few different people. We all have the potential to have any color hair, at least any color that is in our ancestry.  We still tend to have the color of one of our parents hair, but once in a while two people with brown hair will have a redheaded child.  Don’t go jumping to conclusions about unfaithfulness, the red hair may have been a recessive gene and has finally decided to pop up again.
We’re not quite sure why our genes pick a certain hair color over another, but once we do we’ll probably be able to decide preconception what our children are going to look like.  I’m going to make mine a professional football player.

Scientists stack up new genes for height

 An international team of researchers, including a number from the University of North Carolina at Chapel Hill schools of medicine and public health, have discovered hundreds of genes that influence human height.
Their findings confirm that the combination of a large number of genes in any given individual, rather than a simple “tall” gene or “short” gene, helps to determine a person’s stature. It also points the way to future studies exploring how these genes combine into biological pathways to impact human growth.
“While we haven’t explained all of the heritability of height with this study, we have confidence that these genes play a role in height and now can begin to learn about the pathways in which these genes play a role,” said study co-author Karen L. Mohlke, PhD, associate professor of genetics in the UNC School of Medicine.
The study, which appears online Sept. 29, 2010, in the journal Nature, is the result of the largest consortium of researchers to ever study the trait.  The consortium, aptly named GIANT for Genetic Investigation of ANthropometric Traits.
Traits, brought together hundreds of investigators from dozens of countries, to identify which genes affect height in almost two hundred thousand different individuals.
“These investigators had once been competing with each other to find height genes, but then realized that the next step was to combine their samples and see what else could be found,” said Mohlke. “The competitors became collaborators to achieve a common scientific goal.”
That pooling of resources was necessary because the scientists knew that height was a complex genetic trait, with possibly a number of genes of small effect each adding up to influence whether a person would be taller or shorter. In this large study, forty-six smaller genome-wide association studies of height were combined and then analyzed statistically, yielding 180 different regions or genetic loci that influence the trait. “These common gene variants could explain as much as sixteen percent of the variation in height,” said study co-author Kari North, PhD, associate professor of epidemiology in the UNC Gillings School of Global Public Health.
The researchers looked to see whether the 180 regions contained more genes that underlie skeletal growth defects than would be expected if those regions were just chosen randomly across the genome. They found that the genes were not random and could in fact point to functional pathways important in influencing height.
Members of the consortium are working to uncover the “missing heritability” – the proportion of inherited variation in height that is still unexplained. Because this study looked for common genetic variants, the researchers are now going after rare genetic variants that may also play a role.
“This work is giving the field important insights into skeletal growth, height and growth defects,” said Mohlke. “And it is also showing us how similar approaches can be taken to look for genes underlying other common traits and diseases relevant to body size, like type 2 diabetes.” 
Also from UNC is co-author Keri L. Monda, PhD, research assistant professor in epidemiology in the Gillings School of Global Public Health.  The research was funded by the National Institutes of Health.

TRANSFER OF GENES OF HEIGHT AMONG HUMANS

GENETIC EFFECTS ON HEIGHT


Although variance in human height is largely due to genetic traits, the effect of individual genes is very small. This was shown in the doctoral dissertation of Sampo Sammalisto, who defended his thesis at the University of Helsinki. The thesis shows evidence for a new gene locus that affects human height.


Human growth and attained height are determined by a combination of genetic and environmental effects. Height is a fundamental human trait, and it has been estimated that in modern Western societies more than 80 percent of the observed variation in height is determined by genetic factors. Adult height is associated with many diseases as well as socioeconomic and psychosocial factors and health indicators, but little is known of the identity of the specific genes that influence height variation in the general population.

The aim of the thesis work of Sampo Sammalisto, was to identify the genetic variants that influence height in the general population by genome-wide linkage analysis utilizing large family samples. Furthermore, association analysis was used to investigate linked regions of chromosomes and identify the gene loci that cause variance in human stature. CSC’s computing resources were utilized in this research.

The thesis comprised three separate analyses of large family cohorts consisting of: 1) 1,417 individuals from 277 Finnish families (FinnHeight), 2) 8,450 individuals from 3,817 families containing twin pairs from Australia, Denmark, Finland, Sweden, and the UK (EUHeight) and 3) 9,306 individuals from 3,302 families from the United States (USHeight). The research was conducted at the Department of Molecular Medicine of the National Public Health Institute, in the research group directed by Docent Markus Perola and Professor Leena Palotie.

The most important result from this study was establishing statistically significant evidence for a locus in the chromosomal region 1p21 linked to adult height.  Additionally, several other chromosomal regions showed some evidence for linkage to height. Further follow-up studies in the region of 1p21 showed that the collagen 11-alpha-1 gene (COL11A1) residing in the region was associated with adult height. This association was also confirmed in an independent Finnish population cohort (Health 2000) consisting of 6,542 individuals, which showed that homozygous males and females with this gene variant were 1.1 and 0.6 cm taller than the respective controls.

- In this thesis work we identified a variant of the COL11A1 gene that explains 0.1% of height variation in the Finnish population, says Sammalisto.
- The results also indicate that even though genetic effects explain a major proportion of height variance, it is likely that there is a vast number of such genes, although each individual gene causing only an infinitesimal effect on the human height.
Sampo Sammalisto’s doctoral thesis "Search for genetic variants influencing human height" was published in the Publications of the National Public Health Institute, Series A; and in the Biomedical Dissertations series of the University of Helsinki. The thesis is available for public viewing at the E-thesis service of the University of Helsinki.

CSC

CSC, the Finnish IT center for science, is administered by the Ministry of Education. CSC is a non-profit company providing IT support and resources for academia, research institutes and companies: modeling, computing and information services. CSC provides Finland’s widest selection of scientific software and databases and Finland’s most powerful supercomputing environment that researchers can use via the Funet network.

Scientists Discover Gene Linked To Aggressive Behavior in Humans


More than three decades ago, a Dutch schoolteacher, troubled by a pattern of violence among his male relations, traced the pattern's origin to a couple who married in 1780. He concluded his kin must be suffering from an inherited mental disability. Pretending to be a dispassionate outsider, he then wrote up his notes under the title "A Curious Case."
The teacher has long since died. But Friday, his "curious case" earns a page in the annals of science, as a team of researchers from the Netherlands and the United States report that some men in his family harbor a mutant gene that predisposes them to aggressive behavior.
The discovery of what has been dubbed the "aggression gene" marks the first time a specific genetic defect has ever been linked to violent tendencies in humans. It adds to a growing -- and hotly debated -- body of evidence that indicates biological factors, as well as social and environmental causes, contribute to violent behavior.
The researchers found that the over-aggressive men had abnormal genes for a brain chemical that assists in coping with stress. But experts caution that their study, published in today's issue of the journal Science, is limited and cannot be applied to the general population, or used to explain the high rate of violence in the United States.
The study could be as controversial as it is dramatic. Research into the link between biology and crime has come under fire in recent months from those who fear such studies could be used to discriminate against racial minorities. Last year, the National Institutes of Health canceled a conference on the topic, and just last week black activists in Los Angeles protested a similar academic meeting.
Sensitive to these complaints, the Dutch and American scientists stress that the flawed gene, while important, is probably not the sole reason for the family's history of what they call "aggressive outbursts" -- which include a rape that occurred 50 years ago, two arsons and an incident in which one man tried to run over his boss with a car after getting a negative performance evaluation.
"I think this is the most convincing evidence for a biological factor so far," said Dr. Han G. Brunner, the Dutch geneticist who headed the study. "But our study does not give you an idea of how important biological factors are in aggression as a whole."
He noted that while one man in the study continues to have repeated outbursts, his brother -- who also has the genetic abnormality -- has not had one for many years, which suggests social factors and environment also play a role. "There is not a very simple cause-and-effect relationship here."
Others experts are equally reserved in their assessment of the work. "We're still unsure as to what it all means," said Gregory Carey, a University of Colorado psychologist who last year published a review of all scientific studies that have attempted to link crime to genetics. "We are not certain at all the extent of which this gene is present in the general population."

Behavioral genetics: meet molecular biology

During its first 30 years, from roughly 1960 to 1990, the modern discipline of behavioral genetics was based almost entirely on twin and family studies. Those studies made a strong case for the importance of genes in behavior, but the connection always remained loose and statistical. Only in rare cases could a direct connection between a particular gene or set of genes and a particular behavior be made.
In the past decade and a half, all that has changed with the introduction of bioinformatics, genetic engineering and other techniques that allow researchers to measure, analyze and manipulate genetic material rapidly and easily. These techniques have changed the composition of the field of behavioral genetics, engaging the interest of new groups of researchers beyond psychology--molecular biologists, medical doctors and others--who had previously seen behavior as too slippery for biological research.
This shift took place during a time when interest in genetics was exploding. The announcement in 2000 of a completed draft of the human genome--the total complement of genes found in the nucleus of each human cell--and the 50th anniversary of Francis Crick and James Watson's discovery of the structure of DNA in 2003 marked the high points.
Today, expectations of quick rewards from the use of these new techniques are lower than they were during the first flush of excitement. It is now clear that a single gene for complex disorders such as depression is unlikely to exist, let alone be found, even with the most sophisticated methods. Complex behavioral traits, researchers are finding, are influenced by tens if not hundreds of genes, each interacting with the environment and each other in unpredictable ways.
Nonetheless, behavioral genetics continues to hold out the promise of better understanding the biological basis of behavior--hence the field receives strong support from the National Institutes of Health and other grant-making institutions concerned with the intersection of behavior and health.
"There's more and more a proper recognition that you have to understand behavior and genetics and how they work together if you want to understand how people stay healthy or become unhealthy," says John Hewitt, PhD, director of the Institute for Behavioral Genetics at the University of Colorado at Boulder, and chair of the APA Science Directorate's task force on genetics.
New tools and collaborations
The new techniques have not replaced the classic methods in behavioral genetics: twin and family studies that used genetic relatedness to search for genes associated with behavior (see page 46). In fact, twin studies remain one of the best ways of identifying genetic markers linked to complex behavioral traits, according to researchers such as John DeFries, PhD, founder of the journal Behavioral Genetics and former director of the Institute for Behavioral Genetics.
Increasingly, however, such studies are being used not as end-points in themselves, but as stepping stones toward molecular genetics studies that can identify particular genes and their functions, says DeFries.
Ten years ago, before the Human Genome Project and the proliferation of inexpensive genetic tests, a researcher studying a particular behavioral disorder might have had access to tests for three or four genes, says Jonathan Flint, MD, a behavioral geneticist at Oxford University--and the information available about those genes would have been minimal. "Now you click on the Internet and you can find information for the whole genome," he says. Such information is now available not just for the human genome, but also for common laboratory animals such as mice.
This flood of data means that the ability to gather, organize and analyze biological information is becoming increasingly critical. Flint's lab, like many others, has recently hired a bioinformatics specialist to stay up-to-date on methods for mining the gigabytes of data now available.
New techniques are also providing scientists with ways of directly manipulating genes in animals and observing the altered genes' effects on behavior. Mice have proved to be especially amenable to such manipulation. There are now thousands of different strains of single-gene mutants and "knockout" mice--animals in which a single gene has been altered or disabled.
APA genetics task force member Jeanne Wehner, PhD, of the University of Colorado at Boulder, is among those who have studied such knockouts. Although her training is in biochemistry, she and her laboratory do work that is primarily psychological. Using tests of learning and cognition, they look for behavioral differences in strains of genetically manipulated mice.
One knockout-mouse strain they have studied is missing the gene for protein kinase C gamma, a cellular "second-messenger" that communicates between surface receptors and the internal machinery of neurons in the brain and spinal cord.
Like standard mice, these knockouts can be trained to respond to a stimulus in exchange for a reward. However, in experiments where rewards are given for withholding a response--rather than for responding immediately after each stimulus--the mice tend to perform poorly. This, together with their tendency to drink more alcohol than standard mice, is taken as indication of their impulsivity.
Wehner and her colleagues at the University of Colorado are now trying to flesh out the links between protein kinase C gamma and its possible effects on human behaviors such as drug abuse and alcoholism.
One set of studies, led by a member of Wehner's lab, neuroscientist Barbara Bowers, PhD, is examining the effects of protein kinase C within the cell. She is testing the hypothesis that the missing gene affects serotonin receptors, which are known to be involved in emotion and motivation.
Another set of studies, led by Marissa Ehringer, PhD, a human genetics researcher also at the Institute for Behavioral Genetics, is trying to bridge the gap between animals and humans. As part of a larger project on adolescent anti-social behavior, Ehringer is looking for evidence that humans show variation in the gene for protein kinase C gamma and whether that variation has consequences for behavior.
As with much of today's behavioral genetics research, the protein kinase C studies would be impossible without the collaboration of people from a variety of disciplines: the biologists who created the knockout animals, the neuroscientists and psychologists who designed and implemented the animal behavior studies, and the psychologists and medical geneticists who are looking for genetic variation in humans.
Promises and challenges
The proliferation of new techniques has raised expectations of what behavioral genetics can do. But, as many researchers are quick to note, those expectations can sometimes be seriously out of touch with the real promises and challenges of the field.
"The most common misunderstanding--and it's almost willful misunderstanding right now--is that there's going to be a simple answer to a complex question," says Hewitt.
Typically, this takes the form of claims that "the gene" for some complex trait--sexual orientation, for instance, or alcoholism--has been discovered. The media deserve some blame for exaggerating the significance of new research findings, but as Hewitt notes, researchers are not guilt-free: The temptation to play along with the hype in order to increase support for the field is strong.
Recent research is making such a stance increasingly untenable, however. The deeper scientists delve into the genetics of complex behaviors, the more they find that such behaviors are influenced by tens or hundreds of interacting genes, each accounting for only a small portion of the overall variance.
That it is not genes alone, but rather genes in interaction with the environment that produce complex behaviors, is also receiving increasing support, says psychologist Terrie Moffitt, PhD, of the Institute for Psychiatry at King's College London.
Moffitt and her colleagues, for instance, have studied two genes that affect the breakdown and uptake of neurotransmitters in the brain. They have found that the genes have significant effects on depression and antisocial behavior--but only in people who are exposed to particular environmental stressors (see Further Reading below).
Other research is showing that the idea that the heritability of a given trait can be determined once and for all is mistaken. In reality, heritability for complex behavioral traits--the amount of variance in a population accounted for by genetic factors--can vary dramatically within populations (see sidebar).
Even those conducting animal research, which in many ways is easier to interpret than research on humans, have faced challenges. With knockout mice, for instance, developmental psychologists have been quick to point out that removing a gene from an embryonic stem cell and allowing that cell to grow into a genetically modified mouse is not the same as turning the gene off in an otherwise normal adult. The missing gene could have widespread effects on how the organism develops.
In response, says Wehner, geneticists are now producing mice with conditional or inducible knockouts--genes that are inactive only during certain developmental stages, or that can be turned on or off using drugs or changes in environmental conditions. Even so, progress has been slow. Such knockouts are extremely difficult to make, she notes, and they have limitations of their own.
New techniques may help researchers overcome at least some of those challenges. One particularly promising area, says Flint, is the combination of behavioral genetics with visualization tools in biology.
In living animals, including humans, functional MRI and other brain-imaging techniques are providing increasingly high-resolution maps of large-scale neural activity. Meanwhile, in cells, molecular techniques such as tagging enzymes with green fluorescent protein are allowing researchers to watch changes in gene expression as they occur. Researchers are also hoping to make increasingly direct connections between animal models and clinical research, says Hewitt. Right now, a number of interesting candidate genes have been identified in animals, but links to human behavior are sparse. Visualization tools such as those described by Flint may help bridge the gap.
These techniques may bring behavioral geneticists one step closer to their ultimate goal: discovering how neurons--shaped by interactions between genes and the environment--give rise to behavior. "The marrying of those different technologies will enable some of the most exciting science in the next 10 years," says Flint.

TRANSFER OF GENETIC BEHAVIOURS

Early history

The relationship between behaviour and genetics, or heredity, dates to the work of the English scientist Sir Francis Galton (1822–1911), who coined the phrase “nature and nurture.” Galton studied the families of outstanding men of his day and concluded, like his cousin Charles Darwin, that mental powers run in families. Galton became the first to use twins in genetic research and pioneered many of the statistical methods of analysis that are in use today. In 1918 British statistician and geneticist Ronald Aylmer Fisher published a paper that showed how Gregor Mendel’s laws of inheritance applied to complex traits influenced by multiple genes and environmental factors.
The first human behavioral genetic research on intelligence and mental illness began in the 1920s, when environmentalism (the theory that behaviour is a result of nongenetic factors such as various childhood experiences) became popular and before Nazi Germany’s abuse of genetics made the notion of hereditary influence abhorrent. Although genetic research on human behaviour continued throughout the following decades, it was not until the 1970s that a balanced view came to prevail in psychiatry that recognized the importance of nature as well as nurture. In psychology, this reconciliation did not take hold until the 1980s. Much behavioral genetic research today focuses on identifying specific genes that affect behavioral dimensions, such as personality and intelligence, and disorders, such as autism, hyperactivity, depression, and schizophrenia.

Methods of study

Quantitative genetic methods are used to estimate the net effect of genetic and environmental factors on individual differences in any complex trait, including behavioral traits. In addition, molecular genetic methods are used to identify specific genes responsible for genetic influence. Research is carried out in both animals and humans; however, studies using animal models tend to provide more-accurate data than studies in humans because both genes and environment can be manipulated and controlled in the laboratory. By mating related animals such as siblings for many generations, nearly pure strains are obtained in which all offspring are genetically highly similar. It is possible to screen for genetic influence on behaviour by comparing the behaviour of different inbred strains raised in the same laboratory environment. Another method, known as selective breeding, evaluates genetic involvement by attempting to breed for high and low extremes of a trait for several generations. Both methods have been applied to a wide variety of animal behaviours, especially learning and behavioral responses to drugs, and this research provides evidence for widespread influence of genes on behaviour.
Because genes and environments cannot be manipulated in the human species, two quasi-experimental methods are used to screen for genetic influence on individual differences in complex traits such as behaviour. The twin method relies on the accident of nature that results in identical(monozygotic, MZ) twins or fraternal (dizygotic, DZ) twins. MZ twins are like clones, genetically identical to each other because they came from the same fertilized egg. DZ twins, on the other hand, developed from two eggs that happened to be fertilized at the same time. Like other siblings, DZ twins are only half as similar genetically as MZ twins. To the extent that behavioral variability is caused by environmental factors, DZ twins should be as similar for the behavioral trait as are MZ twins because both types of twins are reared by the same parents in the same place at the same time. If the trait is influenced by genes, then DZ twins ought to be less similar than MZ twins. Forschizophrenia, for example, the concordance (risk of one twin’s being schizophrenic if the other is) is about 45 percent for MZ twins and about 15 percent for DZ twins. For intelligence as assessed by IQtests, the correlation, an index of resemblance (0.00 indicates no resemblance and 1.00 indicates perfect resemblance), is 0.85 for MZ twins and 0.60 for DZ twins for studies throughout the world of more than 10,000 pairs of twins. The twin method has been robustly defended as a rough screen for genetic influence on behaviour.

Genes Influence Behavior

Our genetic makeup, as well as environmental influences, play a large role in determining why we behave as we do.

KEY POINTS

  • Classic or Mendelian genetics examines how genes are passed from one generation to the next.
  • Developmental genetics is the study of how genes influence behavior.
  • Behavioral genetics is the study of how animals (including humans) behave.
  • There are many ways to manipulate genetic makeup, such as by cross-breeding for certain characteristics.
  • It is difficult to determine whether genetics ("nature") or the environment ("nurture") have a stronger influence on behavior, and it is largely believed that human behavior is an intricate result of both.

TERMS

  • behavioral genetics
    The field of study that examines the role of genetics in animal (including human) behaviors; it often sparks the nature versus nurture debate. 
  • developmental genetics
    The study of the process by which organisms grow and develop.
  • ethology
    The scientific study of human and animal behaviour.
  • genetics
    The branch of biology that deals with the transmission and variation of inherited characteristics, in particular chromosomes and DNA.

The influence of genes on behavior has been well established in the scientific community. To a large extent, who we are and how we behave is a result of our genetic makeup. While genes do not determine behavior, they play a role in what we do and why we do it.
Behavioral genetics studies heritability of behavioral traits, and it is an overlap of genetics, psychology, and ethology (the scientific study of humans and animals). Developmental genetics, similarly, is the study of how genes influence behaviors. Genetics play a large role in when and how learning, growing, and development occurs. For example, although environment has an effect on the walking behavior of infants and toddlers, children do not usually begin walking before a certain time that is predetermined by genetics. The genetic makeup of a child predetermines an age range for when a child will begin walking, but the influences in the environment determine how early or late the event will actually occur.
Classic or Mendelian genetics, developed by Gregor Mendel , examines how genes are passed from one generation to the next, as well as how the presence or absence of a gene can be determined via sexual reproduction. Gregor Mendel is known as the "father of modern genetics", and his work with plant hybridization (specifically pea plants) demonstrated that certain traits follow particular patterns. This is referred to as the law of Mendelian inheritance.
Gregor Mendel: father of genetics
Mendel's work with pea plants demonstrated that certain traits follow particular patterns.
The ways in which genes can be manipulated can and does have a huge influence on behavioral preferences. Breeding for certain behavioral characteristics can be done through gene manipulation. For example, some dogs are bred specifically to be good hunters. In another example, Seymour Benzer discovered he could breed certain fruit flies with others to create distinct behavioral characteristics and change their circadian rhythms. Genetics have also been successfully manipulated to create a healthy crop of honeybees and decrease the number of diseased bees.

Genetics and the Environment

It is difficult to determine whether genetics ("nature") or the environment ("nurture") have a stronger influence on behavior, and it is largely believed that human behavior is an intricate result of both. For example, a preference for a particular food could be genetically based, it could be because you ate it growing up, or it could be a combination of both. In most cases, behavior is the result of a dynamic interplay between nature and nurture.
Studies on identical twins are often used to determine what can be attributed to genetic influences and what can be attributed to environmental influences. Identical twins share the same genotype, meaning their genetic makeup is the same. Researchers have discovered, however, that the phenotype (or the observable expression of a gene) of identical twins grows apart as they age. Our genes influence how we respond to our environment, and at the same time the expression of our genes are changed by the environment around us; therefore the relationship between genetic and environmental influences cannot be easily separated.

What Is a Gene?

Look closely at the chromosomes and you'd see that each is made of bundles of looping coils. If you unraveled these coils, you'd have a six-foot long double strand of deoxyribonucleic acid-DNA.
A DNA molecule is a twisted ladder-like stack of building blocks called nucleotides. There are four types of DNA nucleotides-adenine, cytosine, guanine, and thymine-or A, C, G, and T, for short.
 
If you could peer into any one of your body's 50 trillion cells, you'd find a fantastically complex and busy world. At the center of this world you'd find a nucleus containing 46 molecules called chromosomes-23 from your mother and 23 from your father. These chromosomes are basically an instruction set for the construction and maintenance of... you.
 
These two long stacks of building blocks fit together like two sides of zipper, but there's a rule involved: adenine only pairs with thymine, and cytosine only pairs with guanine. So each rung in the DNA ladder is a pair of nucleotides, and each pair is either an A stuck to a T or a C stuck to a G.
 
You've got six billion of these pairs of nucleotides in each of your cells, and amongst these six billion nucleotide pairs are roughly 23,000 genes. A gene is a distinct stretch of DNA that determines something about who you are. (More on that later.) Genes vary in size, from just a few thousand pairs of nucleotides (or "base pairs") to over two million base pairs.

X-Ray Vision

Figuring out the structure of DNA was a major challenge for scientists working in the mid-20th century. DNA is tiny, just two nanometers across, 2000 times thinner than a human hair. That's too small to see clearly with even the best light microscope.
 
An x-ray diffraction pattern helped solved the mystery. British chemist Rosalind Franklin made this image by shooting a beam of x-rays at a DNA sample, then capturing on film a record of how the x-rays were bent, or diffracted (see image at right).
 
Biophysicists James Watson and Francis Crick analyzed the picture and concluded that it must have been made by a double-stranded helix, the now-familiar twisted ladder shape of DNA. They announced their results in 1953, and later won the Nobel Prize.
 

GENOCURE

Overview

GeneCure has developed a patented platform technology of gene transfer based on a primate lentivirus. This novel gene transfer technology has the ability to efficiently transfer genes into primary human cells without causing harm to humans. This technology will be employed for developing gene-based therapeutics for human diseases including both inherited and infectious diseases. Current research and development is focused on using this technology to develop human vaccines against HIV, Hepatitis C, Hepatitis B, and SARS.

What is gene transfer technology?

Gene transfer is defined simply as a technique to efficiently and stably introduce foreign genes into the genome of target cells. Genes are the basic hereditary units of all life. It is our genes that provide the blueprints necessary to produce all proteins in our bodies, and our proteins that ultimately perform every biological function. Thus, when a gene is stably introduced into a target cell the protein encoded by the gene is produced.
Gene transfer technologies were originally developed as a research tool for investigating gene expression and function. However, as new gene transfer technologies are developed and old technologies refined, the potential applications have expanded dramatically. Currently, there are a number of gene transfer technologies available which vary greatly in their efficiency of gene transfer and the types of cells they are capable of delivering genes into. Genes can be delivered into cells using lipid-based vectors, naked DNA, electroporation (the application of electrical charge to cells), or viruses which are the most efficient gene transfer vectors.
Recently, gene transfer technology has found its way into clinical applications designed to treat inherited diseases, cancer, and infectious diseases such as AIDS. When genes become altered or damaged so that the encoded protein is no longer functional, as is the case for inherited diseases and many cancers, disease development may occur. Disease development can also be the result of an acquired or infectious disease wherein a pathogenic protein or aberrant protein is produced. In either case, gene transfer technologies can be used to deliver a therapeutic gene into patients. For human clinical applications, gene transfer technologies must be designed that are capable of efficiently delivering genes into primary human cells without harming the recipient. In general, a carrier molecule known as a “vector” is used to deliver the therapeutic gene into target cells. The most commonly used vector for clinical gene transfer applications is a virus which has been genetically engineered to carry the therapeutic gene, but does not have the ability to multiply or cause disease (Figure below).

Lentiviral vectors as gene delivery systems

It is not surprising that the most efficient gene transfer technologies available today exploit the natural ability of viruses to infect and deliver genes into animal cells. Scientists have engineered viruses into gene delivery vectors or carriers that do not cause disease or multiply in infected cells. Oncoretroviruses are the most widely used viral vectors thus far because the retroviral genome inserts into the target cell’s genome following infection. As a result, retroviral vectors can permanently deliver a gene to target cells. However, the use of oncoretroviruses is limited by their ability to infect only dividing cells and by their limited success at establishing stable gene expression in humans. To circumvent these problems, alternative gene transfer technologies are being developed that are capable of delivering genes to a wide range of human cells including non-dividing cells such as neurons. One such gene transfer technology is based on lentiviruses.
Lentiviruses are a family of retroviruses known as slow viruses because symptoms do not generally appear until long after the initial infection. Like all retroviruses, lentiviruses insert their genome into the infected cell’s genome following infection resulting in stable long-term gene expression. Unique to lentiviruses is the ability to naturally infect both dividing and non-dividing cells. Thus, lentiviral-based vectors can be used to deliver genes into non-dividing human cells. This feature greatly expands the scope of potential gene transfer applications.
In developing lentiviral vectors, DNA encoding some or all of the viral genes is removed and replaced with the foreign gene. Thus, the viral vector is designed to be able to enter the cell, deliver the gene, but does not have the ability to replicate or cause disease once inside. The continued development of lentiviral vectors will be critical for the advancement of clinical gene transfer as a viable treatment option for a variety of diseases including genetic disorders and infectious diseases.

GeneCure has developed a lentiviral-based gene transfer technology

GeneCure has developed a patented platform technology of gene transfer based on a primate lentivirus, the simian immunodeficiency virus. This novel gene transfer technology has the ability to efficiently transfer genes into primary human cells without causing harm to humans. This technology will be used to develop vaccines for the prevention and treatment of human diseases.

How GeneCure’s lentiviral-based gene transfer technology works

GeneCure’s patented gene transfer technology is based on a primate lentivirus, the simian immunodeficiency virus (SIV). The company’s lentiviral gene transfer vector (SimVec) is a genetically engineered SIV genome that lacks the genes necessary for viral replication. A therapeutic gene can be introduced into the vector through standard molecular biology techniques. Virus particles encoding the therapeutic gene can be produced in a specialized cell line called a packaging cell line. Virus particles containing the therapeutic gene can then be collected and used to infect and deliver the gene to target cells. Importantly, the virus is capable of infecting and delivering the therapeutic gene to target cells including non-dividing human cells but is unable to multiply and spread to other cells. Because lentiviruses stably integrate into the target cell’s genome, the therapeutic gene can be expressed long-term and is replicated and passed on to all daughter cells during cell division.

Advantages of GeneCure’s gene transfer technology

Efficient gene delivery into primary cells

Current clinical gene transfer is hampered by the lack of effective means to deliver genes into primary human cells. The most commonly used gene transfer technologies in clinical studies are retroviral-based vectors derived from murine retroviruses. Unfortunately, these vectors have limited potential for clinical applications due to their inability to infect non-dividing cells. To address this concern, scientists have taken advantage of lentiviruses, which have the natural ability to infect non-dividing mammalian cells. Lentiviral-based vectors including those based on human immunodeficiency virus, HIV-1, have been developed to deliver genes to non-dividing human cells. However, as HIV-1 is a major human pathogen, the use of HIV-1-based gene transfer technology poses significant concerns for use in human gene transfer applications. GeneCure’s unique technology is based on the simian immunodeficiency virus (SIV), a lentivirus family member that does not cause disease in humans. Thus, GeneCure’s gene transfer technology can effectively deliver genes into human cells including non-dividing and terminally differentiated cells without the risks associated with an HIV-1-based approach.

Safety profile in primate model

In order for viral vectors to be worthy of clinical applications, they must be proven safe in animal models. The primary concern when using retroviruses for human gene transfer applications is the generation of replication-competent retrovirus (RCR). Studies performed in rhesus monkeys to monitor formation of replication-competent virus have validated GeneCure’s gene transfer technology as a safe delivery system for future use in clinical studies.

Stable long-term expression of gene

Because lentiviruses permanently integrate into the target cell’s genome, lentiviral vectors allow for stable long-term expression of the gene. Numerous reports demonstrate stable expression of reporter genes for greater than nine months. Additionally, unlike commonly used onco-retroviral vectors, where transcriptional silencing of the gene has been observed in numerous reports, no transcriptional silencing has been observed with lentiviral vectors. Thus, use of lentiviral vectors may overcome the challenges hindering current gene transfer technologies.

No pre-existing immunity

An important consideration when using viral vectors for clinical gene transfer applications is the presence of pre-existing immunity in the target population. Pre-existing immunity occurs when a patient has been previously exposed to the natural virus, as is common for vectors based on the adenovirus (cause of the common cold) and canarypox virus (a harmless relative of smallpox). Previous exposure the virus prepares the patient’s body to quickly mount an immune response should it encounter the virus again. As a result, use of these viral vectors in patients with pre-existing immunity may dampen the effectiveness of the vector due to unwanted immune responses directed at the vector itself. Pre-existing immunity can limit both the ability of the vector to efficiently deliver the gene to target cells as well as limit the duration of gene expression due to immune-mediated destruction of infected cells. In addition, pre-existing immunity can reduce the efficiency of vector re-administration, limiting the usefulness of boosting or re-immunization with the same vector.
GeneCure’s gene transfer technology is based on the simian immunodeficiency virus (SIV), which is not a human pathogen. Accordingly, this technology can be used in clinical gene transfer applications without the problems associated with pre-existing immunity. This includes the ability to re-administer the viral vector to patients as necessary.

Broad host range

GeneCure’s unique gene transfer technology allows production of lentiviral particles which have incorporated the vesicular stomatitis virus G protein (VSV-G) into the viral envelopes. Incorporation of VSV-G envelope protein permits the viral particles to infect a broad range of mammalian and non-mammalian host cells including human, primate, mouse, hamster, and fish cells. This technology greatly expands the applications of gene transfer technology to include studies using cell types which are resistant to infection with other vectors and to non-mammalian studies.

Stable high titer production of viral particles

Many viral-vector mediated gene transfer applications, particularly clinical applications, require a large quantity of viral vector. As a result, viral vectors must be produced at high titers and must be able to withstand further concentration. GeneCure’s unique gene transfer technology allows production of lentiviral particles which have incorporated the vesicular stomatitis virus G protein (VSV-G) into the viral envelopes. Incorporation of VSV-G into viral particles greatly increases the amount and stability of vector produced. Viral vector can be consistently produced at a biological titer of 108 Transducting Units (TU)/ml and can be concentrated to 1011 TU/ml by ultracentrifugation.

Potential applications of GeneCure’s gene transfer technology

GeneCure’s SimVec gene transfer technology has been designed as a multi-use gene product platform. Because the technology can be used to introduce any foreign gene into virtually any cell type, the potential applications are endless.

Clinical gene transfer applications

The most obvious and potentially most beneficial application of GeneCure’s gene transfer technology is the development of gene-based therapeutics to combat human disease. The lentiviral-based gene transfer technology can efficiently and stably deliver virtually any therapeutic gene safely into human primary cells. Thus, this technology can be used in clinical gene transfer applications designed to treat any number of human diseases including inherited disease, acquired diseases such as cancer, and infectious diseases. GeneCure will license its lentiviral-based gene transfer technology rights to other organizations developing a wide range of clinical gene transfer products.

Vaccine Development

In addition, GeneCure’s gene transfer technology will allowed for the development of innovative vaccine designs. The technology can be used to generate either preventive or therapeutic vaccines against infectious diseases such as AIDS, SARS, malaria, tuberculosis, hepatitis A, B and C viruses, influenza virus, La Crosse virus, and Ebola virus. GeneCure will be developing its own proprietary gene-based vaccines for the treatment of many human diseases including HIV, Hepatitis B, Hepatitis C, and SARS.

Production of transgenic animals

A transgenic animal is an organism that has had DNA introduced into one or more of its cells artificially. Transgenic animals are produced by introducing the DNA of interest into embryonic stem (ES) cells. ES cells containing the DNA insert are then injected into the embryo of a pregnant female; the embryo is implanted into the female’s uterus and allowed to develop. As the animal develops, every cell derived from the modified ES cells contains the specific DNA insert. In this way, whole animals can be produced with the desired modified DNA. Transgenic animals are powerful tools for studying gene function and testing drugs. This type of technology can be used for the development of transgenic livestock and plants, to produce therapeutic proteins and antibodies on an industrial scale, and even to produce disease-resistant crops.
GeneCure’s lentiviral-based gene transfer technology can be used to efficient deliver the DNA of interest into embryonic stems cells of virtually any cell type including mammalian and non-mammalian cells. Thus, this technology can be used to generate transgenic animals, including those that have proven challenging using other methods.

Gene Silencing using siRNAs

Before a gene can be expressed as its protein product, the DNA encoding the gene is copied into a messenger RNA (mRNA) intermediate. It is this mRNA intermediate that is translated into the final protein product. Interfering with the mRNA intermediate is one method of silencing gene expression and is a powerful tool for genetic analysis in vivo and in vitro. Genes can be silenced through the use of small inhibitory RNAs (siRNAs). siRNAs are small molecules that play a crucial role in the destruction of RNA. siRNAs can be designed to target a specific mRNA and to turn off the expression of a specific gene of interest.
Viral vectors are commonly used to deliver siRNAs into cells or whole animals. GeneCure’s unique lentiviral-based gene transfer technology can be used to deliver siRNAs to mammalian and non-mammlian cells in vitro and in vivo. Even though use of siRNAs is still relatively new, its application has already allowed rapid evaluation of gene functions, and will most likely advance the development of innovative gene-based therapeutics. To date lentiviral-based vectors have been used to deliver stable and targeted siRNAs into primary mammalian cells, stem cells, and transgenic animals.

Stem Cell Manipulation

It has proven particularly challenging to genetically manipulate stem cells. Currently, onco-retroviruses are the most widely used gene transfer vectors. However, onco-retroviruses cannot efficiently deliver genes into stem cells. GeneCure’s lentiviral-based gene transfer technology offers unique biological properties that allow efficient and stable gene delivery into stem cells.

Animal models for human disease

Many human genetic and acquired diseases can be modeled by introducing a gene mutation or an entire gene into a mouse or other animal. While similar genetic manipulations can be achieved in tissue culture cells, expression of the gene in whole organisms provides for a much more comprehensive and physiologically relevant interpretation of the genes normal function. Animal models of human diseases are invaluable tools that provide both a better understanding of the disease and a model in which novel therapeutic approaches can be tested. GeneCure’s lentiviral-based gene transfer technology can be used to produce transgenic animals that model human diseases including diseases that affect non-dividing cells like Parkinson’s disease which affects neurons.

Gene Discovery

Although sequencing of the human genome has been completed, the physiological function of many genes remains to be elucidated. GeneCure’s lentiviral-based gene transfer technology can be used to deliver genes with unknown functions into mammalian cells in order to evaluate their functions. This technology can also be used to screen genes for therapeutic properties, with the aim of discovering novel therapeutic approaches to treat human diseases.

Reporter or marker gene expression in vitro and in vivo

Reporter or marker genes are often introduced into cells or whole organisms in order to track a specific cell population. They are used in countless research applications such as monitoring the spread of tumor cells in animal models of cancer. GeneCure’s lentiviral-based gene transfer technology allows efficient gene delivery into virtually any mammalian and non-mammalian cell type. This technology can be used to deliver a reporter or marker gene into both tissue culture cells and whole organisms.

Thursday, 12 June 2014

VERTICLE GENE TRANSFER

an microorganisms take up genetic material from plants and integrate it into their genomes? Could this be a way for genes from genetically engineered plants to spread in the environment? Safety research has been looking into these questions for almost twenty years.

Vertical gene transfer: Nature’s system for higher organisms

The transfer of genetic material to offspring, or the inheritance of genes by subsequent generations, is an essential basis of the evolutionary process. The most common form of gene transfer for higher organisms is sexual reproduction. In the case of higher plants, genetic information is passed along to the next generation by pollination. This is called vertical gene transfer.
Bild vergrößern
Horizontal gene transfer: From plants to microorganisms
Horizontal gene transfer
The movement of genetic material between unrelated species is known as horizontal gene transfer. This phenomenon is known to occur in bacteria. One way this can happen is the direct incorporation of free DNA by bacterial cells. This direct form of gene transfer, for instance in the soil or in the digestive tract of animals, is the most commonly predicted scenario for the transfer of genetic material from transgenic plants to microorganisms.
So far, horizontal gene transfer can only be demonstrated under optimised laboratory conditions. It was shown that horizontal transfer of genes from plants into bacteria occurs extremely infrequently, and it is therefore difficult to detect.
Ongoing safety research is studying transgenic plants to see if horizontal gene transfer to microorganisms is possible, common, or if it would cause any considerable consequences. One example of such a concern is with antibiotic resistance genes that are found in some GM plants. Antibiotic resistance genes are used as marker genes in the development of transgenic plants. They help scientists find out which cells successfully incorporated the gene of interest. GM crops developed with systems for marker gene removal are a very recent devlopment. The maize line LY038 with enhanced lysine content was recently submitted to the EU for authorisation and is free of marker genes. It is hoped that GMOs without marker genes will simplify safety assessments.